Follow the DISC MEDICINE INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was reported on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN QUISEL. All data is openly available.
Analysts rate DISC MEDICINE INC Strong Buy (bullish), based on 12 analysts. Average price target: US$101.58.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
DISC Medicine Inc is a company focused on developing innovative therapies for diseases related to mental health. It is listed on NASDAQ under the ticker XNAS.